New Frontiers in Male Hypogonadism: Are We Over-Treating Low Testosterone?

New Frontiers in Male Hypogonadism Are We Over-Treating Low Testosterone   Abstract Male hypogonadism has emerged as one of the most intensively debated topics in men’s health over the past two decades. Advances in laboratory testing, increased awareness of androgen deficiency, and widespread direct to consumer marketing have

BPH Treatment Guidelines 2025: Expert-Validated Algorithm for Patient Care

BPH Treatment Guidelines 2025: Expert-Validated Algorithm for Patient Care   Introduction Benign prostatic hyperplasia (BPH) treatment guidelines continue to evolve as the condition affects an overwhelming majority of aging men, with prevalence rates reaching 60% by age 60 and escalating to 80% by age

New Frontiers in Male Hypogonadism: Are We Over-Treating Low Testosterone?